Efficacy, safety, and optimal use of isoosmolar contrast medium (Iodixanol) in diagnostic and interventional procedures: A Thai multidisciplinary expert meeting report
DOI:
https://doi.org/10.46475/asean-jr.v27i1.966Keywords:
contrast media, osmolality, acute kidney injury, patient safetyAbstract
Contrast media are used in clinical practice for diagnostic and therapeutic purposes. To discuss the position of iso-osmolar contrast media (IOCM) in diagnostic and interventional procedures in Thailand, an expert advice meeting, including neurologists, cardiologists, nephrologists, radiologists, radiologic technologists and radiologic nurses, was organized to discuss the use of IOCM and low-osmolar contrast media, in general and in specific risk groups. Topics discussed included acute kidney injury, cardiovascular events, patient discomfort, allergic reactions, and high-risk groups. The experts agreed that IOCM has an overall beneficial safety profile as compared to low-osmolar contrast media. With the use of IOCM, patients have a low risk of allergic reactions, and a reduced risk of contrast-associated acute kidney injury. Moreover, the patient will feel less pain. Therefore, IOCM is considered particularly useful in patients at high risk of acute kidney injury, especially in procedures that involve significant contrast exposure.
Downloads
References
Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE. The severity of acute kidney
injury predicts progression to chronic kidney disease. Kidney Int [Internet]. 2011
[cited 2025 Dec 25];79:1361-9. Available from: https://doi.org/10.1038/ki.2011.42
Ad-hoc working group of ERBP; Fliser D, Laville M, Covic A, Fouque D, Vanholder R,
Juillard L, et al. A European Renal Best Practice (ERBP) position statement on the
Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on
acute kidney injury: part 1: definitions, conservative management and contrastinduced
nephropathy. Nephrol Dial Transplant [Internet]. 2012 [cited 2025 Dec
;27:4263-72. Available from: https://doi.org/10.1093/ndt/gfs375
Kooiman J, Le Haen PA, Gezgin G, de Vries JP, Boersma D, Brulez HF, et al. Contrastinduced
acute kidney injury and clinical outcomes after intra-arterial and intravenous
contrast administration: risk comparison adjusted for patient characteristics by
design. Am Heart J [Internet]. 2013 [cited 2025 Dec 25];165:793-99, 9.e1. Available
from: https://doi.org/10.1016/j.ahj.2013.02.013
Andreucci M, Faga T, Serra R, De Sarro G, Michael A. Update on the renal toxicity
of iodinated contrast drugs used in clinical medicine. Drug Healthc Patient Saf
[Internet]. 2017 [cited 2025 Dec 25];9:25-37. Available from: https://doi.org/10.2147/
dhps.S122207
Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic
effects in high-risk patients undergoing angiography. N Engl J Med [Internet]. 2003
[cited 2025 Dec 25];348:491-9. Available from: https://doi.org/10.1056/NEJMoa
Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, et al.
Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized
double-blind trial of contrast-induced nephropathy in patients with chronic kidney
disease. Circulation [Internet]. 2007 [cited 2025 Dec 25];115:3189-96. Available
from: https://doi.org/10.1161/circulationaha.106.671644
Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, et al. Isoosmolality
versus low-osmolality iodinated contrast medium at intravenous
contrast-enhanced CT: effect on kidney function. Radiology [Internet]. 2008 [cited
Dec 25];248:97-105. Available from: https://doi.org/10.1148/radiol.2481071484
Heinrich MC, Häberle L, Müller V, Bautz W, Uder M. Nephrotoxicity of iso-osmolar
iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of
randomized controlled trials. Radiology [Internet]. 2009 [cited 2025 Dec 25];250:68-
Available from: https://doi.org/10.1148/radiol.2501080833
Dong M, Jiao Z, Liu T, Guo F, Li G. Effect of administration route on the renal safety
of contrast agents: a meta-analysis of randomized controlled trials. J Nephrol
[Internet]. 2012 [cited 2025 Dec 25];25:290-301. Available from: https://doi.org/
5301/jn.5000067
Zhang J, Jiang Y, Rui Q, Chen M, Zhang N, Yang H, et al. Iodixanol versus iopromide
in patients with renal insufficiency undergoing coronary angiography with or
without PCI. Medicine (Baltimore) [Internet]. 2018 [cited 2025 Dec 25];97:e0617.
Available from: https://doi.org/10.1097/md.0000000000010617
Yang X, Huang W, Liu W, Zhu Y, Xu Y, Yang G, et al. The influence of contrast agent's
osmolarity on iodine delivery protocol in coronary computed tomography
angiography: comparison between iso-osmolar iodixanol-320 and low-osmolar
iomeprol-370. J Comput Assist Tomogr [Internet]. 2018 [cited 2025 Dec 25];42:62-7.
Available from: https://doi.org/10.1097/rct.0000000000000651
From AM, Bartholmai BJ, Williams AW, McDonald FS. Iodixanol compared to iohexol
for contrast procedures: a case-matched retrospective cohort study. Acta Radiol
[Internet]. 2008 [cited 205 Dec 26];49:409-14. Available from: https://doi.org/10.1080/
Karlsberg RP, Dohad SY, Sheng R; Iodixanol Peripheral CTA Study Investigator Panel.
Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration
of iodinated contrast media. J Nephrol. 2010;23:658-66.
Breglia A, Godi I, Virzì GM, Guglielmetti G, Iannucci G, De Cal M, et al. Subclinical
contrast-induced acute kidney injury in patients undergoing cerebral computed
tomography. Cardiorenal Med [Internet]. 2020 [cited 2025 Dec 26];10:125-36.
Available from: https://doi.org/10.1159/000505422
Baek J, Jeong HW, Heo YJ, Yun S, Kang M, Kim B, et al. Comparison of safety and
diagnostic efficacy of iohexol 240 mgI/mL, iopamidol 250 mgI/mL, and iodixanol
mgI/mL in cerebral angiography: a prospective, multicenter study. Neurointervention
[Internet]. 2023 [cited 2025 Dec 26];19:82-91. Available from: https://doi.org/
5469/neuroint.2024.00129
De Francesco M, Ronco C, Wacinski PJ, Wessely R, Hernández F, Lamotte M. Economic
impact of contrast-induced acute kidney injury associated with invasive cardiology:
role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain. J Med Econ
[Internet]. 2016 [cited 2025 Dec 26];19:158-68. Available from: https://doi.org/10.3
/13696998.2015.1105809
Keuffel E, McCullough PA, Todoran TM, Brilakis ES, Palli SR, Ryan MP, et al. The
effect of major adverse renal cardiovascular event (MARCE) incidence, procedure
volume, and unit cost on the hospital savings resulting from contrast media use in
inpatient angioplasty. J Med Econ [Internet]. 2018 [cited 2025 Dec 26];21:356-64.
Available from: https://doi.org/10.1080/13696998.2017.1415912
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile
app for systematic reviews. Syst Rev [Internet]. 2016 [cited 2025 Dec 26];5:210.
Available from: https://doi.org/10.1186/s13643-016-0384-4
American College of Radiology. ACR Manual on Contrast Media [Internet]. Reston
(VA): ACR Committee on Drugs and Contrast Media; 2024 [cited 2025 Dec 26].
Available from: https://doi.org/https://www.acr.org/-/media/acr/files/clinical-resources/
contrast_media.pdf
Scolari F, Ravani P. Atheroembolic renal disease. Lancet [Internet]. 2010 [cited 2025
Dec 26];375:1650-60. Available from: https://doi.org/10.1016/s0140-6736(09)62073-0
Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N
Engl J Med [Internet]. 2019 [cited 2025 Dec 26];380:2146-55. Available from: https://
doi.org/10.1056/NEJMra1805256
Wang Z, Wang Q, Gong X. Unveiling the mysteries of contrast-induced acute kidney
injury: new horizons in pathogenesis and prevention. Toxics [Internet]. 2024 [cited
Dec 26];12:620. Available from: https://doi.org/10.3390/toxics12080620
Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and
management of acute kidney injury: a KDIGO summary (Part 1). Crit Care [Internet].
[cited 2025 Dec 26];17:204. Available from: https://doi.org/10.1186/cc11454
Lameire N, Kellum JA; KDIGO AKI Guideline Work Group. Contrast-induced acute
kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2).
Crit Care [Internet]. 2013 [cited 2025 Dec 26];17:205. Available from: https://doi.
org/10.1186/cc11455
Obed M, Gabriel MM, Dumann E, Vollmer Barbosa C, Weißenborn K, Schmidt BMW.
Risk of acute kidney injury after contrast-enhanced computerized tomography: a
systematic review and meta-analysis of 21 propensity score–matched cohort
studies. Eur Radiol [Internet]. 2022 [cited 2025 Dec 26];32:8432-42. Available from:
https://doi.org/10.1007/s00330-022-08916-y
McDonald JS, McDonald RJ, Williamson EE, Kallmes DF. Is Intravenous administration
of iodixanol associated with increased risk of acute kidney injury, dialysis, or mortality?
A propensity score-adjusted study. Radiology [Internet]. 2017[cited 2025 Dec
;285:414-24. Available from: https://doi.org/10.1148/radiol.2017161573
Eng J, Wilson RF, Subramaniam RM, Zhang A, Suarez-Cuervo C, Turban S, et al.
Comparative effect of contrast media type on the incidence of contrast-induced
nephropathy: a systematic review and meta-analysis. Ann Intern Med [Internet].
[cited 2025 Dec 26];164:417-24. Available from: https://doi.org/10.7326/m15-
McCullough PA, Brown JR. Effects of intra-arterial and intravenous iso-osmolar contrast
medium (iodixanol) on the risk of contrast-induced acute kidney injury: a metaanalysis.
Cardiorenal Med [Internet]. 2011 [cited 2025 Dec 26];1:220-34. Available
from: https://doi.org/10.1159/000332384
Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, et al. Outcomes after
angiography with sodium bicarbonate and acetylcysteine. N Engl J Med [Internet].
[cited 2025 Dec 26];378:603-14. Available from: https://doi.org/doi:10.1056/
NEJMoa1710933
Weisbord SD, Palevsky PM, Kaufman JS, Wu H, Androsenko M, Ferguson RE, et al.
Contrast-associated acute kidney injury and serious adverse outcomes following
angiography. J Am Coll Cardiol [Internet]. 2020 [cited 2025 Dec 26];75:1311-20.
Available from: https://doi.org/10.1016/j.jacc.2020.01.023
McCullough PA, Bertrand ME, Brinker JA, Stacul F. A Meta-analysis of the renal safety
of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol
[Internet]. 2006 [cited 2025 Dec 26];48:692-9. Available from: https://doi.org/
1016/j.jacc.2006.02.073
Cheng W, Wu X, Liu Q, Wang HS, Zhang NY, Xiao YQ, et al. Post-contrast acute
kidney injury in a hospitalized population: short-, mid-, and long-term outcome and
risk factors for adverse events. Eur Radiol [Internet]. 2020 [cited 2025 Dec 26];30:
-27. Available from: https://doi.org/10.1007/s00330-020-06690-3
Chang DR, Lu SY, Lin ZH, Kuo CC, Chiang HY. Contrast-related risk of progressing
to ESRD in patients undergoing percutaneous coronary intervention: iohexol vs.
iodixanol: SA-PO086. J Am Soc Nephrol [Internet]. 2023 [cited 2025 Dec 26];34
(11S):746-7. Available from: https://doi.org/10.1681/ASN.20233411S1746d
Cochran ST, Bomyea K, Sayre JW. Trends in adverse events after IV administration
of contrast media. AJR Am J Roentgenol [Internet]. 2001 [cited 2025 Dec 26];176:
-8. Available from: https://doi.org/10.2214/ajr.176.6.1761385
Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. A comparison of nonionic,
low-osmolality radiocontrast agents with ionic, high-osmolality agents during
cardiac catheterization. N Engl J Med [Internet]. 1992 [cited 2025 Dec 26];326:431-6.
Available from: https://doi.org/10.1056/nejm199202133260702
Wei Y, Jiang X, Hibberd M, Sampedro A, Rautenbach J. Estimating the rate of acute
adverse reactions to non-ionic low-osmolar contrast media: a systematic review
and meta-analysis. Eur Radiol [Internet]. 2025 [cited 2025 Dec 26];35:6240-9.
Available from: https://doi.org/10.1007/s00330-025-11526-z
Müller FH. Post-marketing surveillance of the safety profile of iodixanol in the
outpatient CT setting: a prospective, multicenter, observational study of patient
risk factors, adverse reactions and preventive measures in 9953 patients. Rofo
[Internet]. 2014 [cited 2025 Dec 26];186:1028-34. Available from: https://doi.org/
1055/s-0034-1366370
Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS. The relative renal
safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of
randomized controlled trials. JACC Cardiovasc Interv [Internet]. 2009 [cited 2025
Dec 26];2:645-54. Available from: https://doi.org/10.1016/j.jcin.2009.05.002
Hosoya T, Yamaguchi K, Akutsu T, Mitsuhashi Y, Kondo S, Sugai Y, et al. Delayed
adverse reactions to iodinated contrast media and their risk factors. Radiat Med
;18:39-45.
Hunt CH, Hartman RP, Hesley GK. Frequency and severity of adverse effects of
iodinated and gadolinium contrast materials: retrospective review of 456,930 doses.
AJR Am J Roentgenol [Internet]. 2009 [cited 2025 Dec 26];193:1124-7. Available
from: https://doi.org/10.2214/AJR.09.2520
McCullough P, Ng CS, Ryan M, Baker ER, Mehta R. Major adverse renal and
cardiovascular events following intra-arterial contrast media administration in
hospitalized patients with comorbid conditions. Cardiorenal Med [Internet]. 2021
[cited 2025 Dec 26];11:193-9. Available from: https://doi.org/10.1159/000517884
Prasad A, Amin AP, Ryan MP, Gunnarsson C, Brilakis ES. Use of iso-osmolar contrast
media during endovascular revascularization is associated with a lower incidence of
major adverse renal, cardiac, or limb events. Catheter Cardiovasc Interv [Internet].
[cited 2025 Dec 26];99:1335-42. Available from: https://doi.org/10.1002/ccd.
Weiland FL, Marti-Bonmati L, Lim L, Becker HC. Comparison of patient comfort
between iodixanol and iopamidol in contrast-enhanced computed tomography of
the abdomen and pelvis: a randomized trial. Acta Radiol [Internet]. 2014 [cited 2025
Dec 26];55:715-24. Available from: https://doi.org/10.1177/0284185113505277
Rosenberg C, Martínez-Rodrigo JJ, Lonjedo Vicent E, Macho J, Lim L, Todoran TM;
Peripheral Discomfort Study Investigator Panel. Randomized, double-blind study
comparing patient comfort and safety between iodixanol 320 mg I/mL and iopamidol
mg I/mL in patients undergoing peripheral arteriography - the COMFORT II
trial. J Invasive Cardiol 2017 ;29:9-15.
McCullough PA, Capasso P. Patient discomfort associated with the use of intraarterial
iodinated contrast media: a meta-analysis of comparative randomized
controlled trials. BMC Med Imaging [Internet]. 2011 [cited 2025 Dec 26];11:12.
Available from: https://doi.org/10.1186/1471-2342-11-12
Hou QR, Gao W, Sun AM, Wang Q, Qiu HS, Wang F, et al. A prospective evaluation
of contrast and radiation dose and image quality in cardiac CT in children with
complex congenital heart disease using low-concentration iodinated contrast
agent and low tube voltage and current. Br J Radiol [Internet]. 2017 [cited 2025 Dec
;90:20160669. Available from: https://doi.org/10.1259/bjr.20160669
Kim M, Hwang JY, Choo KS, Ryu H, Reid SNS, Kim YW, et al. Comparison of image
quality of abdominopelvic CT in paediatric patients: low osmolar contrast media
versus less iodine-containing iso-osmolar contrast media at different peak kilovoltages.
Clin Radiol [Internet]. 2019 [cited 2025 Dec 26];74:896.e9-.e16. Available from:
https://doi.org/10.1016/j.crad.2019.06.027
Callahan MJ, Iyer RS, Wassner AJ. Is thyroid monitoring warranted in infants and
young children after intravascular administration of iodine-based contrast media?
AJR Am J Roentgenol [Internet]. 2023 [cited 2025 Dec 26];220:144-5. Available from:
https://doi.org/10.2214/ajr.22.28007
Paltiel HJ. Hospitalized children with stable kidney function rarely develop contrastinduced
nephropathy. Radiology [Internet]. 2020 [cited 2025 Dec 26];294:557-8.
Available from: https://doi.org/10.1148/radiol.2019192666
Gilligan LA, Davenport MS, Trout AT, Su W, Zhang B, Goldstein SL, et al. Risk of
acute kidney injury following contrast-enhanced CT in hospitalized pediatric
patients: a propensity score analysis. Radiology [Internet]. 2020 [cited 2025 Dec
;294:548-56. Available from: https://doi.org/10.1148/radiol.2020191931
Dennhardt N, Schoof S, Osthaus WA, Witt L, Bertram H, Sümpelmann R. Alterations
of acid-base balance, electrolyte concentrations, and osmolality caused by nonionic
hyperosmolar contrast medium during pediatric cardiac catheterization. Paediatr
Anaesth [Internet]. 2011 [cited 2025 Dec 26];21 :1119-23. Available from: https://
doi.org/10.1111/j.1460-9592.2011.03706.x
Wright NB, Carty HM, Sprigg A, Kampenes VB, Friis M, Petersen KK, et al. Iodixanol
in paediatric gastrointestinal imaging: safety and efficacy comparison with iohexol.
Br J Radiol [Internet]. 2002 [cited 2025 Dec 26];75:127-35. Available from: https://
doi.org/10.1259/bjr.75.890.750127
Kume K, Yasuoka Y, Adachi H, Noda Y, Hattori S, Araki R, et al. Impact of contrastinduced
acute kidney injury on outcomes in patients with ST-segment elevation
myocardial infarction undergoing primary percutaneous coronary intervention.
Cardiovasc Revasc Med [Internet]. 2013 [cited 2025 Dec 26];14:253-7. Available
from: https://doi.org/10.1016/j.carrev.2013.07.009
Terrenato I, Sperati F, Musicco F, Pozzi AF, di Turi A, Caterino M, et al. Iodixanol
versus iopromide in cancer patients: evidence from a randomized clinical trial. J Cell
Physiol [Internet]. 2018 [cited 2025 Dec 26];233:2572-80. Available from: https://
doi.org/10.1002/jcp.26132
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 The ASEAN Journal of Radiology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Disclosure Forms and Copyright Agreements
All authors listed on the manuscript must complete both the electronic copyright agreement. (in the case of acceptance)
